Alterity Therapeutics Ltd.ASX: ATH

Alterity to Present at Bell Potter Healthcare Conference

· Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Alterity Therapeutics Ltd. announced its participation in the virtual Bell Potter Healthcare Conference, where CEO David Stamler will present. The presentation is scheduled for a specific time in November. Alterity is focused on developing treatments for neurodegenerative diseases, particularly Multiple System Atrophy. The announcement was authorized by the CEO of Alterity Therapeutics.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 12 November 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying...

Alterity Therapeutics Ltd. on 6ix

Story so far

Earlier from Alterity Therapeutics

Later from Alterity Therapeutics

All Alterity Therapeutics news releases